Previous 10 | Next 10 |
Aridis Pharmaceuticals Announces Proposed Public Offering of Common Stock PR Newswire LOS GATOS, Calif. , Sept. 26, 2022 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of n...
Aridis Pharmaceuticals press release ( NASDAQ: ARDS ): Q2 GAAP EPS of -$0.45. Revenue of $0.29M. otal cash, cash equivalents and restricted cash as of June 30, 2022 were approximately $8M. For further details see: Aridis Pharmaceuticals GAAP EPS of -$0.45, re...
Aridis Pharmaceuticals Announces Second Quarter 2022 Financial Results and Business Update PR Newswire Multiple clinical data readouts expected in second half of 2022 LOS GATOS, Calif. , Aug. 16, 2022 /PRNewswire/ -- Aridis Pharmaceuticals, In...
Aridis' Pan-Coronavirus, Inhaled Monoclonal Antibody Cocktail AR-701 Is Protective in Non-Human Primates PR Newswire AR-701 is effective in vitro against SARS-CoV-2 Omicron subvariants, including BA.4 and BA.5 LOS GATOS, Calif. , Aug. 10, 2022 ...
Gainers: REX American Resources ( REX ) +195% . SQL Technologies ( SKYX ) +64% . Athersys ( ATHX ) +66% . JAKKS Pacific ( JAKK ) +34% . Aridis Pharmaceuticals ( ARDS ) +33% . Better Therapeutics ( BTTX ) +32% . Co...
Gainers: Better Therapeutics BTTX +43% . GeoVax Labs ( GOVX ) +22% . Aridis Pharmaceuticals ( ARDS ) +19% . Comera Life Sciences ( CMRA ) +13% . Gracell Biotechnologies ( GRCL ) +13% . Losers: Community Health Systems ( CYH ...
ORLANDO, FL / ACCESSWIRE / June 30, 2022 / RedChip Companies will air a new C-Level interview with Aridis Pharmaceuticals (NASDAQ:ARDS) on The RedChip Money Report® on Bloomberg TV, this Saturday, July 2, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million ...
Gainers: Cogent Biosciences (COGT) +89%. Redbox Entertainment (RDBX) +48%. Alpha Tau Medical (DRTS) +23%. Bright Green Corporation (BGXX) +17%. Aridis Pharmaceuticals (ARDS) +18%. Wah Fu Education Group (WAFU) +14%. Powerbridge Technologies (PBTS) +12%. Hycroft Mining Holding Corporation (HYM...
Gainers: Cogent Biosciences (COGT) +56%. IO Biotech (IOBT) +9%. Celularity (CELU) +6%. PolarityTE (PTE) +6%. Aridis Pharmaceuticals (ARDS) +5%. Losers: Fulcrum Therapeutics (FULC) -48%. Caribou Biosciences (CRBU) -33%. DBV Technologies (DBVT) -18%. Card...
Aridis Pharmaceuticals CEO to Participate in a Fireside Chat Presented by Maxim Group LLC and Hosted by M-Vest on June 7 PR Newswire LOS GATOS, Calif. , June 3, 2022 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company ...
News, Short Squeeze, Breakout and More Instantly...
Aridis Pharmaceuticals Inc. Company Name:
ARDS Stock Symbol:
NASDAQ Market:
Aridis Pharmaceuticals Inc. Website:
Biomerieux (BMXMF) is expected to report for Q1 2024 Conn's Inc. (CONN) is expected to report $-0.65 for Q1 2025 Cognetivity Neurosciences Ltd (CGNSF) is expected to report for quarter end 2024-04-30 Aridis Pharmaceuticals Inc. (ARDS) is expected to report for Q1 2024 China Jo-Jo ...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
Commercial Metals Company (CMC) is expected to report $1 for Q3 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 GMS Inc. (GMS) is expected to report $2.04 for Q4 2024 China Jo-Jo Drugstores Inc. (CJJD) is expected to report for Q4 2024 Eiger BioPharmaceuticals Inc. (EIGR...